DNLI - Denali Therapeutics Inc.
19.7
-0.670 -3.401%
Share volume: 1,452,926
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$20.37
-0.67
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-01-2024 | 11-06-2024 | 02-27-2025 | 05-06-2025 | 08-11-2025 | 11-06-2025 | 02-26-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 132.252 M | 116.593 M | 123.187 M | 129.846 M | 145.580 M | 134.963 M | 137.434 M | 137.365 M | |
| Selling general and admin | 25.236 M | 25.194 M | 24.949 M | 30.059 M | 29.353 M | 32.267 M | 35.484 M | 39.460 M | |
| Research and development | 107.016 M | 91.399 M | 98.238 M | 99.787 M | 116.227 M | 102.696 M | 101.950 M | 97.905 M | |
| Total expenses | 117.715 M | 116.593 M | 123.187 M | 129.846 M | 145.580 M | 134.963 M | 137.434 M | 137.365 M | |
| -0.95% | 5.66% | 5.41% | 12.12% | -7.29% | 1.83% | -0.05% | |||
| Operating income | -117.715 M | -116.593 M | -123.187 M | -129.846 M | -145.580 M | -134.963 M | -137.434 M | -137.365 M | |
| Ebit | -117.715 M | -116.593 M | -123.187 M | -129.846 M | -145.580 M | -134.963 M | -137.434 M | -137.365 M | |
| Pretax income | -101.802 M | -99.026 M | -107.192 M | -114.685 M | -132.970 M | -124.119 M | -126.902 M | -128.447 M | |
| -2.73% | 8.25% | 6.99% | 15.94% | -6.66% | 2.24% | 1.22% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -101.802 M | -99.026 M | -107.192 M | -114.753 M | -132.970 M | -124.119 M | -126.902 M | -128.549 M | |
| 2.73% | -8.25% | -7.05% | -15.87% | 6.66% | -2.24% | -1.30% |